Filings · News reference

Onconetix Files Prospectus For Resale Of Up To 100M Shares Issuable Upon Conversion Of Series F Preferred Stock, Or 2,532% Of Shares Outstanding

Aug 12, 2026, 5:57 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARJul 29, 2026, 9:02 PMSEC EDGAR
8-K filing — Onconetix, Inc. (ONCO)
Filed: 2026-07-29 AccNo: 0001213900-26-082879 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Read original at edgar
ONCO
BenzingaJul 24, 2026, 5:05 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular session. The market value of their outstanding shares is at $17.4 billion. The company's, Q2 earnings came out
Read original at benzinga
CDXS GDTC HOWL HYFT JUNS
Globenewswire IncJul 7, 2026, 1:00 PMNa
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
Onconetix announced that Realbotix, its pending acquisition target, has partnered with Bloom Procurement Services to launch a pilot program deploying socially assistive humanoid robots in UK care settings to address loneliness among elderly residents. Realbotix has been accredited as a supplier on Bloom's public sector marketplace. The acquisition is expected to close in the second half of 2026, subject to shareholder approval and regulatory clearances.
Read original at globenewswire-inc
ONCO